Publications by authors named "Diala Harb"

Claim this Profile
P
Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US.
Erin Mulvey, Jason Shafrin, Kyi-Sin Than, Sanjana Muthukrishnan, Alex Mutebi, Diala Harb

Future Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Rituximab Plus Gemcitabine and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Match-Adjusted Comparative Analysis.
Javier Munoz, Allison Rosenthal, Andrew Ip, Justin M Darrah, Tongsheng Wang, Diala Harb

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancrelipase Treatment of Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis: Rationale and Methodology of a Real-World, Prospective, Observational Study.
Mohamed O Othman, Jens J Kort, Tamas A Gonda, Guru Trikudanathan, Darshan J Kothari, Diala Harb

Pancreas· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic enzyme replacement therapy in advanced adenocarcinoma of the pancreas improved overall survival: a retrospective, single institution study.
Vincent J Picozzi, Margaret T Mandelson, Anas Najjar, Moming Li, Diala E Harb

Oncologist· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD36 With EP 80317 Reduces Remote Inflammatory Response to Hind Limb Ischemia-Reperfusion in Mice.
Hanan Elimam, Jade Gauvin, David N Huynh, Liliane Ménard, Marie-Lynn Al-Hawat, Diala Harb

J Biochem Mol Toxicol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency.
Jodie A Barkin, Diala Harb, Jens Kort, Jamie S Barkin

Pancreas· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Weight Loss and Gastrointestinal Symptoms Suggestive of Exocrine Pancreatic Dysfunction After Acute Pancreatitis.
Anna Evans Phillips, Kohtaro Ooka, Ioannis Pothoulakis, Pedram Paragomi, Nicole Komara, Diala Harb

Clin Transl Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician.
Mohamed O Othman, Diala Harb, Jodie A Barkin

Int J Clin Pract· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.
Abraham Morgentaler, Janet A Benesh, Bela S Denes, Natalia Kan-Dobrosky, Diala Harb

J Sex Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.
Diala Harb, Kim Bujold, Maria Febbraio, Martin G Sirois, Huy Ong

Cardiovasc Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
Roberta Avallone, Annie Demers, Amélie Rodrigue-Way, Kim Bujold, Diala Harb

Mol Endocrinol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Sylvie Marleau, Diala Harb, Kim Bujold, Roberta Avallone, Khadija Iken

FASEB J· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis